Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$492K Sell
1,358
-73
-5% -$25K 0.14% 97
2026
Q1
$503K Buy
1,431
+616
+76% +$220K 0.16% 97
2025
Q4
$267K Sell
815
-47
-5% -$14.9K 0.08% 121
2025
Q3
$243K Sell
862
-252
-23% -$73.1K 0.07% 129
2025
Q2
$311K Sell
1,114
-25
-2% -$7.08K 0.09% 115
2025
Q1
$355K Buy
1,139
+75
+7% +$22.1K 0.11% 110
2024
Q4
$277K Buy
1,064
+24
+2% +$7.12K 0.08% 127
2024
Q3
$335K Buy
1,040
+195
+23% +$63.8K 0.1% 116
2024
Q2
$264K Buy
+845
New +$248K 0.08% 118
2018
Q1
Sell
-1,980
Closed -$343K 109
2017
Q4
$343K Buy
+1,980
New +$350K 0.14% 92

Other funds holding AMGN

Bank of Stockton's AMGN Position: Q2 2026 in Review

Bank of Stockton reduced its Amgen (AMGN) stake by 5.1% in Q2 2026, selling an estimated $25K and leaving 1,358 shares worth $492K. The position accounts for 0.14% of the portfolio, ranked #97.

Bank of Stockton first reported a position in AMGN in Q4 2017 and has held it in 10 quarters since. The position peaked at $503K in Q1 2026. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bank of Stockton held 1,358 shares of Amgen worth $492K as of Q2 2026.
  • Bank of Stockton sold 73 Amgen shares in Q2 2026, an estimated $25K.
  • Amgen made up 0.14% of Bank of Stockton's portfolio in Q2 2026, its #97 holding.
  • Bank of Stockton first reported a position in Amgen in Q4 2017 and has held it in 10 quarters since.
  • Bank of Stockton's Amgen position peaked at $503K in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bank of Stockton's 13F filing for Q2 2026, filed 29 Jul 2026.